Considering the scale and severity of TB in India, it is important to understand the implications of the new WHO guidelines ...

Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published ...

WHO praises Fiji’s commitment to accessible healthcare as the facility consolidates services for faster, seamless treatment.

Before the successful Nix-TB trial, which took place in South Africa from 2015 to 2017, patients with extensively drug-resistant TB (XDR-TB) had to follow a complicated treatment plan for the ...

According to the Minister, the tool is “an investment in the power of data to save lives. Our political will to end TB is ...

A new study projects that US funding cuts to global health aid will have a catastrophic effect on pediatric TB, with children ...

An international study led by Jonathon Campbell at The Institute highlights the powerful health and economic impact of ...

Malaria and tuberculosis (TB) remain two of the most devastating infectious diseases, particularly across the African continent. Despite significant efforts ...

For decades, traditional adrenaline auto-injectors (AAIs) have been the only available treatment for anaphylaxis—a life-threatening allergic reaction.1,2 Yet from today, the UK’s first needle-free ...

Cuts to US health aid could cause 2.5 million more child TB cases and 340,000 deaths in low- and middle-income countries by ...

Emphasising the urgent need for continued vigilance and improved access to advanced treatment options, the National TB ...